171 related articles for article (PubMed ID: 9529278)
1. Effect of hyperinsulinemia on myocardial fluorine-18-FDG uptake.
Ng CK; Soufer R; McNulty PH
J Nucl Med; 1998 Mar; 39(3):379-83. PubMed ID: 9529278
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure.
Taylor M; Wallhaus TR; Degrado TR; Russell DC; Stanko P; Nickles RJ; Stone CK
J Nucl Med; 2001 Jan; 42(1):55-62. PubMed ID: 11197981
[TBL] [Abstract][Full Text] [Related]
3. Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.
Mäki MT; Haaparanta M; Nuutila P; Oikonen V; Luotolahti M; Eskola O; Knuuti JM
J Nucl Med; 1998 Aug; 39(8):1320-7. PubMed ID: 9708500
[TBL] [Abstract][Full Text] [Related]
4. Correlation between myocardial blood flow and fasting glucose metabolism in ischemic heart disease. Quantitative assessment by nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose positron emission tomography.
Watanabe T; Okazaki O; Akutsu Y; Yamanaka H; Michihata T; Katagiri T; Harumi K
Jpn Heart J; 1998 May; 39(3):275-85. PubMed ID: 9711179
[TBL] [Abstract][Full Text] [Related]
5. Regional myocardial blood flow and glucose utilization during fasting and physiological hyperinsulinemia in humans.
Iozzo P; Chareonthaitawee P; Di Terlizzi M; Betteridge DJ; Ferrannini E; Camici PG
Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1163-71. PubMed ID: 11934683
[TBL] [Abstract][Full Text] [Related]
6. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of myocardial FDG uptake in hyperglycemia.
Kubota K; Kubota R; Yamada S; Tada M; Takahashi T; Iwata R
J Nucl Med; 1996 Oct; 37(10):1713-7. PubMed ID: 8862317
[TBL] [Abstract][Full Text] [Related]
8. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose.
Bøtker HE; Böttcher M; Schmitz O; Gee A; Hansen SB; Cold GE; Nielsen TT; Gjedde A
J Nucl Cardiol; 1997; 4(2 Pt 1):125-32. PubMed ID: 9115064
[TBL] [Abstract][Full Text] [Related]
9. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
[TBL] [Abstract][Full Text] [Related]
10. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
[TBL] [Abstract][Full Text] [Related]
11. Insulin action on heart and skeletal muscle FDG uptake in patients with hypertriglyceridemia.
Yokoyama I; Ohtake T; Momomura S; Yonekura K; Kobayakawa N; Aoyagi T; Sugiura S; Yamada N; Ohtomo K; Sasaki Y; Omata M; Yazaki Y
J Nucl Med; 1999 Jul; 40(7):1116-21. PubMed ID: 10405129
[TBL] [Abstract][Full Text] [Related]
12. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
[TBL] [Abstract][Full Text] [Related]
13. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
[TBL] [Abstract][Full Text] [Related]
14. Effect of nicotinic acid on exogenous myocardial glucose utilization.
Stone CK; Holden JE; Stanley W; Perlman SB
J Nucl Med; 1995 Jun; 36(6):996-1002. PubMed ID: 7769458
[TBL] [Abstract][Full Text] [Related]
15. Influence of blood substrate levels on myocardial kinetics of iodine-123-BMIPP.
Kurata C; Wakabayashi Y; Shouda S; Mikami T; Takei Y; Tawarahara K; Sugiyama T; Nakano T; Fujisawa S; Andoh A
J Nucl Med; 1997 Jul; 38(7):1079-84. PubMed ID: 9225794
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero P; Sharp TL; Dence C; Haraden BM; Gropler RJ
J Nucl Med; 2002 Nov; 43(11):1530-41. PubMed ID: 12411556
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of augmented fluorine-18 deoxyglucose uptake in remote normoperfused myocardium in patients with acute coronary syndrome under fasting conditions.
Nakano A; Lee JD; Shimizu H; Yonekura Y; Ueda T
J Nucl Cardiol; 2000; 7(5):454-60. PubMed ID: 11083194
[TBL] [Abstract][Full Text] [Related]
19. A simplified intravenous glucose loading protocol for fluorine-18 fluorodeoxyglucose cardiac single-photon emission tomography.
Martin WH; Jones RC; Delbeke D; Sandler MP
Eur J Nucl Med; 1997 Oct; 24(10):1291-7. PubMed ID: 9323271
[TBL] [Abstract][Full Text] [Related]
20. Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.
Kelley DE; Williams KV; Price JC; Goodpaster B
J Nucl Med; 1999 Nov; 40(11):1798-804. PubMed ID: 10565773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
